Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 285
Filter
1.
J Pers ; 92(2): 620-635, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37269092

ABSTRACT

OBJECTIVE: Across four studies, we examined whether certain personality traits cue prejudice and serve as identity threat cues. BACKGROUND: Stigmatized group members may be vigilant to personality cues that signal prejudice. METHOD: In Study 1 (N = 76), perceivers selected traits and behaviors associated with disagreeableness and closedness to experience as indicators of prejudice. In Studies 2-4, perceivers with stigmatized identities (Total N = 907) learned about a target person who was depicted as disagreeable or agreeable (Studies 2 and 3) and as disagreeable or another trait matched on perceived negativity (i.e., low in conscientiousness, Study 4). RESULTS: Participants perceived the disagreeable target as more discriminatory and hierarchy-endorsing (Studies 2-4), more morally disengaged (Study 3), and more likely to discriminate against stigmatized identity groups (Studies 2 and 4) than the agreeable or low conscientious targets. The relationship between target disagreeableness and perceived discrimination was partially explained by higher perceived hierarchy endorsing beliefs (Studies 2-4) and perceived moral disengagement (Study 3). CONCLUSIONS: This research finds that perceivers with stigmatized identities utilize target disagreeableness as a cue of identity threat, inferring that disagreeable people are more likely to be discriminatory, prejudicial, and hierarchy-endorsing than agreeable and low conscientious people.


Subject(s)
Personality , Prejudice , Humans , Morals , Fear
2.
Proc Natl Acad Sci U S A ; 117(39): 24154-24164, 2020 09 29.
Article in English | MEDLINE | ID: mdl-32929006

ABSTRACT

Science is undergoing rapid change with the movement to improve science focused largely on reproducibility/replicability and open science practices. This moment of change-in which science turns inward to examine its methods and practices-provides an opportunity to address its historic lack of diversity and noninclusive culture. Through network modeling and semantic analysis, we provide an initial exploration of the structure, cultural frames, and women's participation in the open science and reproducibility literatures (n = 2,926 articles and conference proceedings). Network analyses suggest that the open science and reproducibility literatures are emerging relatively independently of each other, sharing few common papers or authors. We next examine whether the literatures differentially incorporate collaborative, prosocial ideals that are known to engage members of underrepresented groups more than independent, winner-takes-all approaches. We find that open science has a more connected, collaborative structure than does reproducibility. Semantic analyses of paper abstracts reveal that these literatures have adopted different cultural frames: open science includes more explicitly communal and prosocial language than does reproducibility. Finally, consistent with literature suggesting the diversity benefits of communal and prosocial purposes, we find that women publish more frequently in high-status author positions (first or last) within open science (vs. reproducibility). Furthermore, this finding is further patterned by team size and time. Women are more represented in larger teams within reproducibility, and women's participation is increasing in open science over time and decreasing in reproducibility. We conclude with actionable suggestions for cultivating a more prosocial and diverse culture of science.


Subject(s)
Reproducibility of Results , Science/trends , Women , Authorship , Humans , Information Dissemination , Open Access Publishing
3.
J Clin Psychol ; 79(4): 1070-1081, 2023 04.
Article in English | MEDLINE | ID: mdl-36417562

ABSTRACT

OBJECTIVES: This study investigated whether therapists' self-assessed time spent on learning activities was associated with treatment outcomes. The study was a replication of Chow et al.'s (2015) study, which showed that the most effective therapists spent more total time on solitary learning activities than less effective therapists. The present study sought to replicate this finding, and it explored the association between 25 specific activities of therapists and clients' treatment outcomes. Also, this study explored which learning activities therapists found most relevant for improving their performance. METHODS: In this naturalistic longitudinal study, data from 2424 outpatients who were being treated by 40 different therapists were analyzed using multilevel analyses. Posttreatment scores on the OQ-45 (controlled for pretreatment client variables) were used to measure treatment outcome. The RAPID Practice-D was used to measure therapists' learning and other activities spent with the aim of improving their therapeutic skills. RESULTS: The results showed that the total amount of time that therapists indicated they spent on learning activities did not predict clients' treatment outcomes. Also, no specific learning activities were related to clients' outcomes. Nevertheless, therapists indicated that they perceived several specific activities to be highly relevant for improving their skills. CONCLUSION: The results showed that therapists' perceptions of how much time they spent on learning activities was not related to their performance. This might suggest that therapists' perceptions of their activities is inaccurate or that they attach value to the wrong activities. It also indicates the importance of not relying solely on the self-assessments of therapists to evaluate a therapist's training and its relationship with outcome.


Subject(s)
Psychotherapy , Self-Assessment , Humans , Psychotherapy/methods , Longitudinal Studies , Treatment Outcome , Learning
4.
Ecol Appl ; 32(6): e2625, 2022 09.
Article in English | MEDLINE | ID: mdl-35397182

ABSTRACT

Myriophyllum spicatum, more commonly known as Eurasian watermilfoil (EWM), is one of the most invasive aquatic plants in North America, causing negative ecological and economic impacts in ecosystems where it proliferates. Many control strategies have been developed and implemented to mitigate EWM growth and spread, although the results are mixed and there is no consensus on lake-specific strategies. Here, we describe the development of a predictive model using a support vector technique, that predicts the success of biological pest control using Euhrychiopsis lecontei (the milfoil weevil), a milfoil specialist, to reduce EWM in lakes. Such a model is informed by lake characteristics (limnological and landscape) and augmentation strategies. To develop our predictive model, we performed a metadata analysis from 133 published peer-reviewed literature and professional reports of milfoil weevil augmentation field experiments that contained information on lake characteristics. The predictive model's algorithm uses a support vector machine (SMV) to learn patterns among lake characteristics, along with the recorded augmentation strategy and the reported success of each study, where success is a measure of EWM change over a season and is recorded in a variety of ways (e.g., EWM biomass change, EWM percent change, EWM visual change, etc.,). Overall, the model results suggests that shallower lakes, more frequent weevil augmentations, and larger weevil overwintering habitat are the most important predictors for EWM reduction success by weevil augmentation. Although watermilfoil weevil augmentation is a promising mitigation strategy, it may not work for all lakes. However, in terms of suggesting weevil augmentation, our model is a valuable tool for lake stakeholders and resource managers, who can use it to determine whether milfoil weevil augmentation, which can be very costly due to the difficulties in finding and raising milfoil weevils, will be a useful and sustainable approach to control EWM in their lake community.


Subject(s)
Ecosystem , Weevils , Animals , Lakes , Machine Learning , Plants
5.
J Endocrinol Invest ; 45(1): 189-197, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34324163

ABSTRACT

PURPOSE: Thyrotropin receptor autoantibodies (TSH-R-Ab) are heterogeneous in their biological function and play a significant role in the pathophysiology of both Graves' disease and Graves' orbitopathy (GO). The clinical significance and utility of determining functional TSH-R-Ab in a Serbian collective were evaluated. METHODS: 91 consecutive patients with GO were included in this study. Total TSH-R-Ab concentration, referred to as TSH-R binding inhibitory immunoglobulins (TBII) was detected using a competitive-binding immunoassay. Stimulating and blocking TSH-R-Ab (TSAb and TBAb) were measured with cell-based bioassays. RESULTS: Stimulating TSAb activity and TBII positivity were detected in 85 of 91 (93.4%) and 65 of 91 (71.4%) patients with GO (P < 0.001). Blocking TBAb activity was observed in only one patient who expressed dual stimulating and blocking TSH-R-Ab activity. The sensitivity rates for differentiating between clinically active versus inactive and mild versus moderate-to-severe GO were 100% and 100% for TSAb, respectively. In contrast, these were 82% and 87% only for TBII. Seven of eight (87.5%) and one of eight (12.5%) euthyroid patients with GO were TSAb and TBII positive, respectively (P < 0.031). TSAb serum levels significantly predicted GO activity compared to TBII (odds ratio, OR, 95%CI: 3.908, 95%CI 1.615-9.457, P = 0.003; versus 2.133, 0.904-5.032, P = 0.084, univariate analysis; and OR 4.341, 95%CI 1.609-11.707, P = 0.004; versus 2.337, 0.889-6.145, P = 0.085 multivariate analysis). CONCLUSION: Stimulating TSAb are highly prevalent in patients with GO and show superior clinical characteristics and predictive potential compared to the traditionally used TBII.


Subject(s)
Autoantibodies , Graves Disease , Graves Ophthalmopathy , Immunoglobulins, Thyroid-Stimulating , Autoantibodies/analysis , Autoantibodies/blood , Female , Graves Disease/complications , Graves Disease/diagnosis , Graves Disease/epidemiology , Graves Disease/immunology , Graves Ophthalmopathy/diagnosis , Graves Ophthalmopathy/epidemiology , Graves Ophthalmopathy/immunology , Humans , Immunoassay/methods , Immunoglobulins, Thyroid-Stimulating/analysis , Immunoglobulins, Thyroid-Stimulating/blood , Male , Middle Aged , Receptors, Thyrotropin/immunology , Serbia/epidemiology , Thyroid Hormones/blood
6.
BMC Geriatr ; 22(1): 484, 2022 06 04.
Article in English | MEDLINE | ID: mdl-35658904

ABSTRACT

BACKGROUND: Falls are the leading cause of injury-related death among older Americans. While some research has found that insomnia heightens falls, health care resource utilization (HCRU) and costs, the impact of insomnia treatments on fall risk, mortality, HCRU and costs in the elderly population, which could be of substantial interest to payers, has not been fully elucidated. This study evaluated the risk of falls and related consequences among adults ≥ 65 years of age treated with common prescription medications for insomnia compared with non-sleep disordered controls. METHODS: This was a retrospective cohort analysis of deidentified Medicare claims from January 2011 through December 2017. Medicare beneficiaries treated for insomnia receiving zolpidem extended-release, zolpidem immediate-release, trazodone, or benzodiazepines were matched with non-sleep disordered controls. The main outcomes were falls, mortality, healthcare resource utilization (HCRU), and medical costs during the 12 months following the earliest fill date for the insomnia medication of interest. Generalized linear models controlled for several key covariates, including age, race, sex, geographic region and Charlson Comorbidity Index score. RESULTS: The study included 1,699,913 Medicare beneficiaries (59.9% female, mean age 75 years). Relative to controls, adjusted analyses showed that beneficiaries receiving insomnia medication experienced over twice as many falls (odds ratio [OR] = 2.34, 95% CI: 2.31-2.36). In adjusted analyses, patients receiving benzodiazepines or trazodone had the greatest risk. Crude all-cause mortality rates were 15-times as high for the insomnia-treated as controls. Compared with controls, beneficiaries receiving insomnia treatment demonstrated higher estimated adjusted mean number of inpatient, outpatient, and emergency department visits and longer length of inpatient stay. All-cause total adjusted mean costs were higher among insomnia treated patients ($967 vs $454). CONCLUSIONS: Individuals receiving insomnia treatment had an increased risk of falls and mortality and higher HCRU and costs compared with matched beneficiaries without sleep disorders. Trazodone and benzodiazepines were associated with the greatest risk of falls. This analysis suggests that significant risks are associated with common, older generation insomnia medication treatments in the elderly. Nonetheless, these results should be interpreted with caution as the use of these medications may be indicative of underlying morbidity with potential for residual confounding.


Subject(s)
Sleep Initiation and Maintenance Disorders , Trazodone , Accidental Falls , Aged , Benzodiazepines/therapeutic use , Delivery of Health Care , Female , Health Care Costs , Humans , Male , Medicare , Retrospective Studies , Sleep Initiation and Maintenance Disorders/drug therapy , Sleep Initiation and Maintenance Disorders/epidemiology , Trazodone/adverse effects , United States/epidemiology , Zolpidem/adverse effects
7.
Aging Ment Health ; 26(3): 570-577, 2022 03.
Article in English | MEDLINE | ID: mdl-33779424

ABSTRACT

OBJECTIVE: During COVID-19 lockdown the enforced social isolation and other pandemic-related changes highly increased the risk of mental health problems. We aimed to discover how elderly people coped with the psychological burdens of pandemic and the social isolation in Hungary. METHODS: This study included 589 (441 females) Hungarian individuals, aged 60-83 (M = 68.1, SD = 4.46). We collected online survey data to reach a wide population of elderly. Results of hierarchical linear modelling and structural equation modelling (SEM) analyses established how the current life-changing circumstances, the intolerance of uncertainty, loneliness and social support influence the mental health (e.g. depression, anxiety, well-being) of the elderly. The model was used to explore how adaptive and maladaptive emotion regulation strategies mediated the effects. RESULTS: Findings showed that perceived change in mood, social connectedness, and quality of life was negatively affected by catastrophizing and loneliness; whereas positive refocusing and contamination fear had a positive effect. According to the SEM analysis, intolerance of uncertainty and loneliness directly affected mental health. Further, maladaptive emotion regulation strategies mediated the connection between intolerance of uncertainty, contamination fear, loneliness and mental health. Whereas adaptive emotion regulation strategy mediated the connection between social support from friends, contamination fear, loneliness and mental health. CONCLUSION: Overall, our research might help the understanding of how external and internal factors contributed to the well-being of elderly people during the COVID-19. The model can also be translated into professional interventions to develop coping strategies among elderly for the challenges of COVID-19 pandemic in their lives.


Subject(s)
COVID-19 , Pandemics , Adaptation, Psychological , Aged , Aged, 80 and over , Communicable Disease Control , Female , Humans , Hungary , Quality of Life , SARS-CoV-2
8.
Article in Spanish | MEDLINE | ID: mdl-35350461

ABSTRACT

The purpose of this special report is to describe chronologically the events that contributed to the development and approval of legislation and subsequent implementation of a school vaccination mandate in order to prevent HPV and HPV-associated cancers in Puerto Rico (PR). Starting in 2010, PR initiated public-policy approvals aimed at improving cancer registries and HPV vaccine coverage through health insurance for adolescents aged 11 to 18 years. In 2014, scientific and community efforts succeeded in documenting the magnitude of morbidity caused by HPV and jointly developing HPV vaccine prevention and promotion strategies. In August 2018, PR became one of the first four territories of the United States of America to implement the HPV vaccine school entry requirement to decrease the incidence of HPV-associated cancers on the island. In 2019, it was enshrined in law that every immunization provider must submit immunization data to the Puerto Rico Immunization Registry. The case of PR demonstrates that public policy-making alongside collaboration between academic, scientific, and community coalitions can achieve population change and measurable outcomes aimed at HPV prevention. Countries with a similar public health problem could adopt efforts similar to those presented herein and align them with the World Health Organization goal of eradicating cervical cancer by 2030.


O propósito deste relatório especial é descrever cronologicamente os eventos que contribuíram para o desenvolvimento e a aprovação de legislação, e a implementação da exigência escolar de vacinação em Porto Rico (PR), a fim de prevenir o HPV e os cânceres associados a ele. A partir de 2010, PR iniciou as aprovações de políticas públicas com o objetivo de aprimorar o registro dos casos de câncer e a cobertura vacinal contra o HPV, por meio de planos de saúde, em adolescentes de 11 a 18 anos. Em 2014, esforços científicos e comunitários permitiram documentar a magnitude das doenças causadas pelo HPV e elaborar conjuntamente estratégias de prevenção e promoção da vacina contra o HPV. Em agosto de 2018, PR foi um dos primeiros quatro territórios dos Estados Unidos da América a implementar a vacina contra o HPV como exigência escolar, a fim de diminuir a incidência de cânceres associados ao HPV na ilha. Em 2019 ficou garantido por lei que todos os vacinadores devem enviar informações ao Registro de Imunização. O caso de PR demonstra que o desenvolvimento de políticas públicas, em conjunto com parcerias entre coalizões acadêmicas, científicas e comunitárias, alcança mudanças populacionais e resultados mensuráveis dirigidos à prevenção do HPV. Países com uma problemática de saúde pública similar poderiam adotar esforços semelhantes aos apresentados e alinhá-los ao objetivo da Organização Mundial da Saúde: a erradicação do câncer cervical até 2030.

9.
J Pharm Technol ; 38(3): 169-173, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35600282

ABSTRACT

Background: The coronavirus disease 2019 (COVID-19) is a novel coronavirus that has caused an unprecedented global pandemic, with few treatment options currently available. Neutralizing monoclonal antibodies (mAbs) are a promising treatment approach to reduce hospitalizations in high-risk patients with mild-to-moderate COVID-19 infections. Objective: The primary objective is to compare hospitalization rates of high-risk patients who tested positive for COVID-19 within 28 days between those who received mAb infusions versus those who did not. Secondary objectives were emergency department (ED) visits and mortality within 28 days of a positive test. Methods: This single-center, institutional review board-approved, retrospective, observational cohort study included patients aged 19 years and older who tested positive for COVID-19 between December 2, 2020 and February 28, 2021. Patients who received the mAbs bamlanivimab or casirivimab/imdevimab were compared with patients who did not receive mAb infusions to examine hospitalization rates, ED visits, and mortality within 28 days of the positive COVID-19 test. Results: A total of 2780 patients were evaluated for inclusion using electronic chart review via Cerner. Of the 1612 patients who met inclusion criteria, 568 received an mAb infusion (mAb group) and 1044 did not (non-mAb group). Baseline characteristics were similar between the 2 groups. Of the patients in the mAb group, 34 (6%) were hospitalized versus 397 (38%) in the non-mAb group. Patients with ED visits included 111 (20%) and 672 (64%) in the mAb and non-mAb groups, respectively. Finally, 5 patients in the mAb group experienced mortality (0.9%) versus 83 (8%) in the non-mAb group. Each endpoint achieved statistical significance with a P value of <0.0001. Conclusion: Monoclonal antibody infusions are effective in preventing hospitalization, ED visits, and mortality in high-risk patients with mild-to-moderate COVID-19.

10.
J Endocrinol Invest ; 44(4): 703-712, 2021 Apr.
Article in English | MEDLINE | ID: mdl-32749654

ABSTRACT

CONTEXT AND PURPOSE: The thyrotropin receptor (TSHR) is the key autoantigen in Graves' disease (GD) and associated orbitopathy (GO). Antibodies targeting the TSHR (TSHR-Ab) impact the pathogenesis and the course of GO. This review discusses the role and clinical relevance of TSHR-Ab in GO. METHODS: Review of the current and pertinent literature. RESULTS: GO is the most common extrathyroidal manifestation of GD and is caused by persistent, unregulated stimulation of TSHR-expressing orbital target cells (e.g. fibroblasts and pre-adipocytes). Serum TSHR-Ab and more specifically, the stimulatory Ab (TSAb) are observed in the vast majority of patients with GD and GO. TSHR-Ab are a sensitive serological parameter for the differential diagnosis of GO. TSHR-Ab can be detected either with conventional binding immunoassays that measure binding of Ab to the TSHR or with cell-based bioassays that provide information on their functional activity and potency. Knowledge of the biological activity and not simply the presence or absence of TSHR-Ab has relevant clinical implications e.g. predicting de-novo development or exacerbation of pre-existing GO. TSAb are specific biomarkers of GD/GO and responsible for many of its clinical manifestations. TSAb strongly correlate with the clinical activity and clinical severity of GO. Further, the magnitude of TSAb indicates the onset and acuity of sight-threatening GO (optic neuropathy). Baseline serum values of TSAb and especially dilution analysis of TSAb significantly differentiate between thyroidal GD only versus GD + GO. CONCLUSION: Measurement of functional TSHR-Ab, especially TSAb, is clinically relevant for the differential diagnosis and management of GO.


Subject(s)
Autoantibodies/blood , Graves Ophthalmopathy , Receptors, Thyrotropin/immunology , Graves Ophthalmopathy/diagnosis , Graves Ophthalmopathy/immunology , Graves Ophthalmopathy/physiopathology , Humans , Immunologic Tests/methods , Symptom Assessment/methods
11.
BMC Public Health ; 21(1): 1938, 2021 10 25.
Article in English | MEDLINE | ID: mdl-34696745

ABSTRACT

BACKGROUND: The Human papillomavirus vaccine (HPV) is an essential tool for the prevention of HPV-related cancers. In Puerto Rico, the Secretary of Health established a school entry requirement of at least one dose of HPV vaccination in girls and boys aged 11 and 12 years, taking effect in August 2018. Our study aimed to examine parents' and guardians' views of unvaccinated children about the process of implementation of the new HPV vaccination school entry policy in Puerto Rico and identify potential barriers and facilitators related to the implementation of this requirement. METHODS: During April through November 2019, we conducted three focus groups (n = 12) and eight in-depth semi-structured interviews with parents of children aged 11 and 12 who had not yet initiated the HPV vaccine series. The interview topics addressed were: perception of vaccination, HPV vaccine and it is inclusion as new school entry requirement practice, procedure of the sources of information, influencers, and willingness to change. The interviews were recorded and transcribed by our staff members. We identified emergent themes through thematic analysis. RESULTS: The participants' perspective on the HPV vaccine school requirement was mixed. Lack of information of the HPV vaccines and lack of communication about the school-entry requirement were the themes most mentioned in the interviews. Moreover, previous negative experiences from friends or family members and adverse effects deterred some participants from vaccinating their kids. We discussed barriers in the process of soliciting an exemption. CONCLUSION: Most barriers mentioned by study participants are modifiable. Information about the HPV vaccine mandate's implementation and educational materials regarding HPV vaccine safety need to be provided to address parents' concerns related to the vaccine's side effects. Schools (teachers, principal directors, and administrative staff), the government, and parent organizations need to be part of these efforts. This multilevel approach will help to improve disseminating information about HPV vaccination to clarify doubts and misinformation among parents.


Subject(s)
Papillomavirus Infections , Papillomavirus Vaccines , Child , Female , Health Knowledge, Attitudes, Practice , Humans , Male , Papillomavirus Infections/prevention & control , Parents , Patient Acceptance of Health Care , Policy , Puerto Rico , Schools , Vaccination
12.
BMC Public Health ; 21(1): 1286, 2021 07 01.
Article in English | MEDLINE | ID: mdl-34210308

ABSTRACT

BACKGROUND: In August 2018, Puerto Rico (PR) became the 4th state or territory in the United States to adopt a human papillomavirus (HPV) vaccine school-entry requirement, for students 11-12 years old. Evidence suggests that the content of media coverage may impact people's perception of HPV vaccine and their willingness to vaccinate. This study aimed to analyze the content of digital news coverage related to the implementation of the policy in PR. METHODS: A content review was conducted of digital media published from January 2017 through December 2018. The content reviewed was carried out in two steps: 1) creating a matrix to summarize each article's content about the policy and 2) qualitative analysis using a grounded theory approach. RESULTS: The search resulted in 34 articles obtained from 17 online local and international news outlets that reported the policy's implementation. Analyses showed that 61% of the news articles did not mention the number of required doses, and 79% discussed the new policy concerning cancer prevention. In 2017, news coverage focused mostly on describing the policy, while 2018 coverage focused on controversies surrounding the implementation. Neutral emergent codes included: 1) Description of the policy; 2) Information about HPV related cancers; and 3) General information about HPV vaccine. Negative emergent codes included: 1) infringement to patient and parental autonomy; 2) Hesitancy from the political sector, and 3) Hesitancy from groups and coalitions. Positive content included: 1) knowledge and acceptance of HPV vaccine for cancer prevention; 2) importance of education and protective sexual behaviors; and 3) new vaccination law proposal. CONCLUSIONS: Most of the media coverage in PR was neutral and included limited information related to the vaccine, HPV, and HPV-related cancers. Neutral and negative themes could influence public concerns regarding the new policy, as well as HPV vaccination rates in PR.


Subject(s)
Papillomavirus Infections , Papillomavirus Vaccines , Child , Humans , Internet , Papillomavirus Infections/prevention & control , Policy , Puerto Rico , Schools , United States , Vaccination
13.
Pediatr Emerg Care ; 37(4): e174-e178, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-29912086

ABSTRACT

OBJECTIVE: The management of injured children is a required element of pediatric emergency medicine (PEM) fellowship training. Given the relatively infrequent exposure of trainees to major trauma, it is important to understand how programs train fellows and assess their competency in pediatric trauma. METHODS: An online survey was sent to 84 PEM fellowship program directors (PDs). Program directors were asked to describe their program's characteristics, the degree of fellow independence, educational techniques used to train fellows in trauma, and their expectation of fellows' competency in 14 core trauma-related skills upon graduation. Program directors were classified as having high expectations if they anticipated that graduating fellows could perform 12 trauma skills or more independently. RESULTS: Fifty-nine programs (70%) responded. Although most programs (55, 93%) identified as pediatric trauma centers, fellows at the majority of programs (41, 69%) spent some or all of their trauma experience at an outside hospital. Only a minority of programs (17, 29%) allowed fellows to lead pediatric trauma resuscitations as independent attendings without precepting. Programs used over a dozen different educational methods to varying degrees. Less than half of programs (28, 47%) used a formal trauma curriculum. Whereas 33 PDs (56%) had high expectations, only 9 (15%) expected fellows to be able to perform all 14 skills. CONCLUSIONS: There is considerable variability in how PEM fellows are trained to care for injured children. Most PDs do not realistically expect fellows to be able to perform all recommended trauma skills after graduation. Our findings highlight the need for further research and efforts to standardize the training of PEM fellows in pediatric trauma.


Subject(s)
Emergency Medicine , Internship and Residency , Pediatric Emergency Medicine , Child , Curriculum , Education, Medical, Graduate , Emergency Medicine/education , Fellowships and Scholarships , Humans , Surveys and Questionnaires
14.
J Endocrinol Invest ; 43(6): 767-777, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31834613

ABSTRACT

PURPOSE: The dual antiproliferative mechanism of mycophenolate appears to be beneficial in Graves' orbitopathy (GO). METHODS: Safety data from the two published mycophenolate trials and the original database of the European Group on Graves' Orbitopathy (EUGOGO) trial were systematically analyzed. Treatment efficacy stratified by individual visual parameters of activity and severity were compared. RESULTS: A total of 129 adverse events (AE) involving 50 patients (29.4%) were noted among all mycophenolate-treated patients. Mycophenolate sodium plus intravenous glucocorticoid (MPS + GC) group of the EUGOGO trial recorded significantly more AE (55.4% versus 4.6% of patients affected) and serious adverse events (SAE) (12.5% versus 0%) than mycophenolate mofetil (MMF) group of the Chinese trial. None of those SAE was side effect (SE). Most SE in MPS + GC group were mild. Gastrointestinal disorders, infection and liver dysfunction affected 8.8%, 7.1% and 1.2% of all mycophenolate-treated patients (versus 5.4%, 5.4% and 1.2% of all patients on GC monotherapy, respectively). MPS + GC did not significantly increase the risk of infection or liver dysfunction when compared to GC monotherapy. No cytopenia, serious infection or treatment-related mortality was reported. The much higher AE rates of mycophenolate trials in other autoimmune diseases or transplantations suggested that major mycophenolate toxicities were mostly dose- and duration dependent. Mycophenolate, either as monotherapy or as combination, achieved better overall response than GC monotherapy. CONCLUSION: The risk-benefit ratio of low-dose mycophenolate treatment in active moderate-to-severe GO is highly favorable given its reassuring safety profile with low rate of mild-to-moderate SE and promising efficacy.


Subject(s)
Antibiotics, Antineoplastic/administration & dosage , Graves Ophthalmopathy/drug therapy , Mycophenolic Acid/administration & dosage , Randomized Controlled Trials as Topic/methods , Antibiotics, Antineoplastic/adverse effects , Dose-Response Relationship, Drug , Drug Therapy, Combination , Gastrointestinal Diseases/chemically induced , Glucocorticoids/administration & dosage , Glucocorticoids/adverse effects , Graves Ophthalmopathy/epidemiology , Humans , Mycophenolic Acid/adverse effects
15.
J Endocrinol Invest ; 43(2): 123-137, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31538314

ABSTRACT

PURPOSE: Immunohistochemistry of orbital tissues offers a correlation between the microscopic changes and macroscopic clinical manifestation of Graves' orbitopathy (GO). Summarizing the participation of different molecules will help us to understand the pathogenesis of GO. METHODS: The pertinent and current literature on immunohistochemistry of human orbital tissue in GO was reviewed using the NCBI PubMed database. RESULTS: 33 articles comprising over 700 orbital tissue samples were included in this review. The earliest findings included the demonstration of HLA-DR and T cell (to a lesser extent B cell) markers in GO orbital tissues. Subsequent investigators further contributed by characterizing cellular infiltration, confirming the presence of HLA-DR and TSHR, as well as revealing the participation of cytokines, growth factors, adhesion molecules and miscellaneous substances. HLA-DR and TSHR are over-expressed in orbital tissues of GO patients. The inflammatory infiltration mainly comprises CD4 + T cells and macrophages. Cytokine profile suggests the importance of Th1 (especially in early active phase) and Th17 immunity in the pathogenesis of GO. Upregulation of proinflammatory/profibrotic cytokines, adhesion molecules and growth factors finally culminate in activation of orbital fibroblasts and perpetuation of orbital inflammation. The molecular status of selected parameters correlates with the clinical presentation of GO. CONCLUSION: Further investigation is warranted to define precisely the role of different molecules and ongoing search for new players yet to be discovered is also important. Unfolding the molecular mechanisms behind GO will hopefully provide insights into the development of novel therapeutic strategies and optimize our clinical management of the disease.


Subject(s)
Graves Ophthalmopathy/metabolism , Inflammation Mediators/metabolism , Orbit/chemistry , Orbit/metabolism , Animals , B-Lymphocytes/chemistry , B-Lymphocytes/metabolism , Cytokines/analysis , Cytokines/metabolism , Graves Ophthalmopathy/pathology , Humans , Inflammation Mediators/analysis , Orbit/pathology , T-Lymphocytes/chemistry , T-Lymphocytes/metabolism
16.
Neurosurg Focus ; 49(5): E8, 2020 11.
Article in English | MEDLINE | ID: mdl-33130613

ABSTRACT

The Emergency Medical Treatment and Active Labor Act (EMTALA) protects patient access to emergency medical treatment regardless of insurance or socioeconomic status. A significant result of the COVID-19 pandemic has been the rapid acceleration in the adoption of telemedicine services across many facets of healthcare. However, very little literature exists regarding the use of telemedicine in the context of EMTALA. This work aimed to evaluate the potential to expand the usage of telemedicine services for neurotrauma to reduce transfer rates, minimize movement of patients across borders, and alleviate the burden on tertiary care hospitals involved in the care of patients with COVID-19 during a global pandemic. In this paper, the authors outline EMTALA provisions, provide examples of EMTALA violations involving neurosurgical care, and propose guidelines for the creation of telemedicine protocols between referring and consulting institutions.


Subject(s)
Betacoronavirus , Brain Concussion/therapy , Centers for Medicare and Medicaid Services, U.S./legislation & jurisprudence , Coronavirus Infections/therapy , Emergency Medical Services/legislation & jurisprudence , Pneumonia, Viral/therapy , Telemedicine/legislation & jurisprudence , Brain Concussion/epidemiology , COVID-19 , Centers for Medicare and Medicaid Services, U.S./trends , Coronavirus Infections/epidemiology , Emergency Medical Services/trends , Humans , Pandemics , Pneumonia, Viral/epidemiology , SARS-CoV-2 , Telemedicine/trends , Tertiary Care Centers/legislation & jurisprudence , Tertiary Care Centers/trends , United States/epidemiology
17.
Neurosurg Focus ; 49(4): E10, 2020 10.
Article in English | MEDLINE | ID: mdl-33002862

ABSTRACT

OBJECTIVE: Blunt cerebrovascular injury (BCVI) is associated with high rates of neurological morbidity and mortality. The detection and management of BCVI has improved with advances in imaging and sensitive screening protocols. Few studies have explored how these injuries specifically affect the geriatric population. The purpose of this retrospective analysis was to investigate the presentation and prognosis of BCVI in the elderly population and to assess its clinical implications in the management of these patients. METHODS: All patients presenting to the University of Cincinnati (UC) level I trauma center between February 2017 and December 2019 were screened for BCVI and entered into the prospectively maintained UC Neurotrauma Registry. Patients with BCVI confirmed by CT angiography underwent retrospective chart reviews to collect information regarding demographics, positive screening criteria, cause of injury, antithrombotic agent, injury location, Denver Grading Scale, hospital and ICU length of stay, and discharge disposition. Patients were divided into geriatric (age ≥ 65 years) and adult (age < 65 years) subgroups. Continuous variables were analyzed using the Student t-test and categorical variables with the Pearson chi-square test. RESULTS: Of 124 patients with BCVI, stratification by age yielded 23 geriatric and 101 adult patients. Injury in the geriatric group was associated with significantly higher mortality (p = 0.0194). The most common cause of injury in the elderly was falls (74%, 17/23; p < 0.0001), whereas motor vehicle accidents were most common in the adult group (38%, 38/100; p = 0.0642). With respect to the location of injury, carotid (p = 0.1171) and vertebral artery (p = 0.6981) injuries did not differ significantly for the geriatric group. The adult population presented more often with Denver grade I injuries (p < 0.0001), whereas the geriatric population presented with grade IV injuries (p = 0.0247). Elderly patients were more likely to be discharged to skilled nursing facilities (p = 0.0403) and adults to home or self-care (p = 0.0148). CONCLUSIONS: This study is the first to characterize BCVI to all cervical and intracranial vessels in the geriatric population. Older age at presentation is significantly associated with greater severity, morbidity, and mortality from injury, with no preference for the particular artery injured. These findings carry important clinical implications for adapting practice in an aging population.


Subject(s)
Carotid Artery Injuries , Cerebrovascular Trauma , Wounds, Nonpenetrating , Adult , Aged , Cerebrovascular Trauma/diagnostic imaging , Cerebrovascular Trauma/epidemiology , Computed Tomography Angiography , Humans , Retrospective Studies , Vertebral Artery
19.
Adv Physiol Educ ; 43(3): 414-422, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31408387

ABSTRACT

The purpose of this study was to evaluate the effect of different metacognitive interventions on knowledge and regulation of cognition, as well as academic performance (i.e., exam and final grades) in three sections of an undergraduate human anatomy and physiology course. All targeted classes were randomly assigned to one of three groups (reflection practice, passive acquisition of knowledge, and collaborative learning), and the interventions were implemented after exam 1. A pre- and posttest survey was administered during the semester (during week 2 and after exam 2), and exam and final course grades were collected at the end of the semester. The final sample included 129 students. A significant interaction of group and time was observed for knowledge of cognition: it increased in the reflection practice group, did not change in the collaborative learning group, and it decreased in the passive acquisition of knowledge. The interventions did not produce any significant interactions or main effects on regulation of cognition, exam scores, or final grades. Along with more research on metacognition in physiology education contexts, it is recommended to further examine the ways in which such data can be collected, as self-report measures only tell part of the story.


Subject(s)
Academic Performance/psychology , Educational Measurement/methods , Health Occupations/education , Metacognition , Students, Health Occupations/psychology , Teaching/psychology , Female , Humans , Male , Metacognition/physiology
20.
Med Care ; 56(12): 1024-1031, 2018 12.
Article in English | MEDLINE | ID: mdl-30256279

ABSTRACT

BACKGROUND: Determinants of prescribing psychoactive medications for symptom management in older adults remain underexamined despite known risks and cautions concerning these medications. OBJECTIVE: To examine independent and combined effects of pain, concurrent insomnia and depression symptoms on psychoactive medications supplied to older adults with osteoarthritis (OA). RESEARCH DESIGN: Survey data on pain, insomnia, and depression obtained from OA patients screened for a randomized controlled trial were used to identify predictors of psychoactive medication supply [opioids, sedatives, tricyclic antidepressants (TCAs), and non-TCAs] over a 4-year period. SUBJECTS: Group Health Cooperative patients with a diagnosis of OA (N=2976). MEASURES: Survey data on pain (Graded Chronic Pain Scale), insomnia (Insomnia Severity Index), and depression (Patient Health Questionnaire-8); and medications supply assessed from electronic medical records. RESULTS: In negative binomial models, pain [incidence rate ratio (IRR), 2.8-3.5; P<0.001], insomnia (IRR, 2.0; P<0.001), and depression (IRR, 1.5; P<0.05) each independently predicted opioid supply. Insomnia (IRR, 3.2; P<0.001) and depression (IRR, 3.0; P<0.001) each independently predicted sedative supply. Pain (IRR, 2.1; P<0.05) and insomnia (IRR, 2.0; P<0.05) independently predicted TCA supply, whereas only depression (IRR, 2.2; P<0.001) independently predicted non-TCA supply. Combined effects of pain and insomnia/depression on these medications were additive and increased the rate of medication supply 1.5-7.5 times. Combined effects increased with insomnia or depression severity. CONCLUSIONS: Concurrent insomnia and depressive symptoms predicted increased supply of opioids, sedatives, and antidepressants after accounting for pain, indicating the importance of sleep and mood disorders as factors increasing supply of these medications.


Subject(s)
Chronic Pain/drug therapy , Comorbidity , Depression/drug therapy , Osteoarthritis/therapy , Psychotropic Drugs/supply & distribution , Psychotropic Drugs/therapeutic use , Sleep Initiation and Maintenance Disorders/drug therapy , Aged , Electronic Health Records , Female , Humans , Male , Pain Measurement , Retrospective Studies , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL